Daratumumab in rituximab-refractory autoimmune haemolytic anaemia
- PMID: 34180543
- DOI: 10.1111/bjh.17655
Daratumumab in rituximab-refractory autoimmune haemolytic anaemia
References
-
- Michel M, Chanet V, Dechartres A, Morin A-S, Piette J-C, Cirasino L, et al. The spectrum of Evans syndrome in adults: new insight into the disease based on the analysis of 68 cases. Blood. 2009;114(15):3167-72.
-
- Hill QA, Stamps R, Massey E, Grainger JD, Provan D, Hill A. The diagnosis and management of primary autoimmune haemolytic anaemia. Br J Haematol. 2017;176(3):395-411.
-
- Jäger U, Barcellini W, Broome CM, Gertz MA, Hill A, Hill QA, et al. Diagnosis and treatment of autoimmune hemolytic anemia in adults: recommendations from the First International Consensus Meeting. Blood Rev. 2020;41:100648.
-
- Niethammer D, Kümmerle-Deschner J, Dannecker GE. Side-effects of long-term immunosuppression versus morbidity in autologous stem cell rescue: striking the balance. Rheumatology. 1999;38(8):747-50.
-
- Hofmann K, Clauder AK, Manz RA. Targeting B cells and plasma cells in autoimmune diseases [Internet]. Vol. 9, Frontiers in Immunology. Frontiers Media S.A.; 2018 [cited 2021 Mar 24]. p. 835. Available from: www.frontiersin.org.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources